These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24448760)

  • 1. Novel strategies for toxicological risk assessments.
    Roy A; Akbarsha MA
    ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
    von Aulock S
    ALTEX; 2013; 30(1):1. PubMed ID: 23451363
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.
    Leist M; Lidbury BA; Yang C; Hayden PJ; Kelm JM; Ringeissen S; Detroyer A; Meunier JR; Rathman JF; Jackson GR; Stolper G; Hasiwa N
    ALTEX; 2012; 29(4):373-88. PubMed ID: 23138508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009.
    Vogel R
    ALTEX; 2009; 26(3):223-6. PubMed ID: 19907908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity testing: the need for new maps for the future.
    Balls M
    Altern Lab Anim; 2011 Oct; 39(5):417-8. PubMed ID: 22103936
    [No Abstract]   [Full Text] [Related]  

  • 6. The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products.
    Indans I
    Toxicol Lett; 2002 Feb; 127(1-3):177-82. PubMed ID: 12052656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
    Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
    Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Approaches to Testing and Assessment.
    Casati S
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():51-55. PubMed ID: 29604238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
    Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
    Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicology and stem cells: New frontiers.
    Caloni F; Ferrari M; De Angelis I
    ALTEX; 2014; 31(1):94. PubMed ID: 24448761
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotoxicity: hazard identification and risk assessment.
    Luster MI; Kimber I
    Hum Exp Toxicol; 1996 Dec; 15(12):947-8. PubMed ID: 8981097
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of skin sensitizers using alternative methods to animal experimentation.
    Johansson H; Lindstedt M
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):110-7. PubMed ID: 24548737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicology is IN: in silico, in vitro, integrated testing strategy.
    Caloni F; Benfenati E; Sambuy Y
    ALTEX; 2016; 33(2):187-8. PubMed ID: 27032091
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to: Bayesian network integrated testing strategy and beyond.
    Jaworska J
    ALTEX; 2013; 30(3):391. PubMed ID: 23861082
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictive toxicology today: the transition from biological knowledge to practicable models.
    Benigni R
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):989-92. PubMed ID: 27351633
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrated testing strategies for use in the EU REACH system.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2006 Aug; 34(4):407-27. PubMed ID: 16945008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of reconstructed skin models in pharmaco-toxicological trials.
    Damour O; Augustin C; Black AF
    Med Biol Eng Comput; 1998 Nov; 36(6):825-32. PubMed ID: 10367477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REACH testing requirements must not be driven by reproductive toxicity testing.
    Spielmann H; Vogel R
    Altern Lab Anim; 2006 Aug; 34(4):365-6. PubMed ID: 16945004
    [No Abstract]   [Full Text] [Related]  

  • 20. Reproductive Toxicology. Editorial.
    Piersma AH
    Reprod Toxicol; 2010 Aug; 30(1):1. PubMed ID: 20580665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.